EA202092184A2 - Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле - Google Patents

Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле

Info

Publication number
EA202092184A2
EA202092184A2 EA202092184A EA202092184A EA202092184A2 EA 202092184 A2 EA202092184 A2 EA 202092184A2 EA 202092184 A EA202092184 A EA 202092184A EA 202092184 A EA202092184 A EA 202092184A EA 202092184 A2 EA202092184 A2 EA 202092184A2
Authority
EA
Eurasian Patent Office
Prior art keywords
neurokinin
receptor
antagonists
therapeutic
body fat
Prior art date
Application number
EA202092184A
Other languages
English (en)
Other versions
EA202092184A3 (ru
Inventor
Хамид Ховейда
Грэм Фрейзер
Original Assignee
Огеда Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Огеда Са filed Critical Огеда Са
Publication of EA202092184A2 publication Critical patent/EA202092184A2/ru
Publication of EA202092184A3 publication Critical patent/EA202092184A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению антагонистов рецептора нейрокинина-3 (NK3R) для терапевтического лечения патологических излишних жировых отложений на теле и/или предотвращения прибавления жировых отложений на теле у пациентов. Также настоящее изобретение относится к косметологическому способу для стимулирования потери избытка жировых отложений на теле, согласно которому вводят антагонист рецептора NK-3.
EA202092184A 2015-11-06 2016-03-16 Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле EA202092184A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15193513 2015-11-06

Publications (2)

Publication Number Publication Date
EA202092184A2 true EA202092184A2 (ru) 2021-03-31
EA202092184A3 EA202092184A3 (ru) 2021-06-30

Family

ID=75262255

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092184A EA202092184A3 (ru) 2015-11-06 2016-03-16 Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле

Country Status (1)

Country Link
EA (1) EA202092184A3 (ru)

Also Published As

Publication number Publication date
EA202092184A3 (ru) 2021-06-30

Similar Documents

Publication Publication Date Title
EA201791901A1 (ru) Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле
EA202091134A1 (ru) Экзосомы для иммуноонкологической и противовоспалительной терапии
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
PT3377637T (pt) Composições para uso em métodos para o tratamento de ferimentos, transtornos e doenças da pele
EA201792304A1 (ru) Комбинированная терапия для лечения рака
IL276383B1 (en) Treatment of ophthalmological diseases
EA201691567A1 (ru) Способы лечения легких травм головного мозга
IL264069A (en) Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation
EA201891609A1 (ru) Производные 3-((гетеро-)арил)алкил-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
EA202190281A1 (ru) Производные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диаза-спиро[4,5]декана
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
EA202091307A1 (ru) Накожная система мониторинга состояния человека
EA201792560A1 (ru) Наночастицы для применения в качестве терапевтической вакцины
EA201792445A1 (ru) Новые амидогетероарилароилгидразидэтины
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине
MX2019000600A (es) Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello.
SG11202007082PA (en) Composition used for therapeutic treatment of skin disease
EA202092184A2 (ru) Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле
PT3271015T (pt) Antagonistas do recetor nk-3 para tratamento terapêutico ou cosmético do excesso de gordura corporal
IL274132A (en) Treatment of skin problems
GB201904012D0 (en) Regulation of blood glucoe via human microbioma
IT201700070978A1 (it) Apparecchiatura per il trattamento terapeutico del corpo umano
EA201991866A1 (ru) Комбинированная терапия